• No results found

schizoaffective disorder

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

... Several clinical studies have established the efficacy, safety, and tolerability of long-acting risperidone admin- istered once every 2 weeks in patients with schizophrenia or schizoaffective disorder. ...

10

A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy

A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy

... typically presents with fever, muscle rigidity, and altered mental status [22] and should be differentiated from cata- tonic stupor complicated by respiratory infection. In this case, the clear consciousness of the ...

5

Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT

Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT

... SchizophrEnia, schizoaffective disorder and first episode psychosis programme (STEPWISE) intervention was intended to promote weight loss through lifestyle ...

197

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: protocol for a pilot trial

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: protocol for a pilot trial

... This pilot study is a double-blind, randomised, placebo- controlled trial investigating the use of once-daily liraglu- tide subcutaneous injection in obese or overweight people with schizophrenia, schizoaffective ...

10

Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE) : randomised controlled trial

Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE) : randomised controlled trial

... Methods: In this randomised controlled trial, we recruited adults with schizophrenia, schizoaffective disorder or first episode psychosis from ten mental health organisations in England. Participants were ...

34

Effective lifestyle interventions to improve type II diabetes self management for those with schizophrenia or schizoaffective disorder: a systematic review

Effective lifestyle interventions to improve type II diabetes self management for those with schizophrenia or schizoaffective disorder: a systematic review

... or schizoaffective disorder, ii) the intervention must target a lifestyle factor associated with diabetes self- care, such as problem-solving skills, education classes, diet or exercise, iii) the outcome ...

9

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder

... From medical records we formed a cohort of patients diagnosed with schizophrenia (F20) or schizoaffective disorder (F25). We then evaluated groups of patients who were newly treated with each ...

5

A Genome-Wide Scan for Linkage to Chromosomal Regions in 382 Sibling Pairs with Schizophrenia or Schizoaffective Disorder

A Genome-Wide Scan for Linkage to Chromosomal Regions in 382 Sibling Pairs with Schizophrenia or Schizoaffective Disorder

... Chromosome 22q became a focus of attention after the report of Pulver et al. (3) suggesting linkage to this chromo- some in schizophrenia and descriptions of schizophrenia- like symptoms in patients with velocardiofacial ...

10

ProtocadherinX/Y, a Candidate Gene-Pair for Schizophrenia and Schizoaffective Disorder: A DHPLC Investigation of Gonomic Sequence

ProtocadherinX/Y, a Candidate Gene-Pair for Schizophrenia and Schizoaffective Disorder: A DHPLC Investigation of Gonomic Sequence

... and two Costa Rican families. These included 214 affected individuals (62 females and 152 males; 84 sibling-pairs: 44 male–male, nine female–female, and 34 mixed-sex; 11 sib- ling-trios: two all male, two all female, and ...

9

Polysubstance induced relapse of schizoaffective disorder refractory to high dose antipsychotic medications: a case report

Polysubstance induced relapse of schizoaffective disorder refractory to high dose antipsychotic medications: a case report

... of schizoaffective disorder was brought to our emergency department by the police in a state of extreme agitation, combativeness, and paranoia after use of cannabis and crystal ...

7

A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder

A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder

... schizoaffective disorder. The diagnosis of schizophrenia or schizoaffective dis- order was established by a consultant psychiatrist using the Structured Clinical Interview for the Diagnostic and ...

12

Prospective cohort study of the relationship between neuro cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder

Prospective cohort study of the relationship between neuro cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder

... Background: There is a broad literature suggesting that cognitive difficulties are associated with violence across a variety of groups. Although neurocognitive and social cognitive deficits are core features of ...

17

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and&nbsp;results<div><br /></div>

... The current study adds information regarding the benefit of C/M-ECT with regard to the most severe and chronic subgroup of adult patients with schizophrenia, who are hospitalized continuously for a long duration. ...

10

Effects of Metformin on Weight Loss and Metabolic Control in Obese Patients With Schizophrenia and Schizoaffective Disorder: A Randomized Double-Blind Controlled Clinical Trial

Effects of Metformin on Weight Loss and Metabolic Control in Obese Patients With Schizophrenia and Schizoaffective Disorder: A Randomized Double-Blind Controlled Clinical Trial

... The patients would be excluded from the study if drug complications or intolerance to dose increasing happened. Weight loss and the improvement of some metabolic indices in patients with schizophrenia and ...

10

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty four months: implications for clinical practice

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty four months: implications for clinical practice

... Several large observational studies of patients with BD and schizoaffective disorder (SAD) have been conducted and subsequently published [17-24]. Among them, the Bipolar Comprehensive Outcomes Study (BCOS) ...

11

A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting

A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting

... Aripiprazole has been shown to be efficacious and well tolerated for the treatment of schizophrenia in short- term (4-6 weeks) [11-15] and longer-term (26 and 52 weeks) clinical trials [9,12,16,17]. However, whether ...

9

Study protocol: a randomised controlled trial of cognitive remediation for a national cohort of forensic mental health patients with schizophrenia or schizoaffective disorder

Study protocol: a randomised controlled trial of cognitive remediation for a national cohort of forensic mental health patients with schizophrenia or schizoaffective disorder

... and schizoaffective disorder scored more than three standard deviations below the popula- tion mean on the MATRICS Consensus Battery for cog- nitive deficits in schizophrenia ...

13

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder

... Abstract: Schizoaffective disorder (SCA) is a chronic and disabling mental illness that presents with mixed symptoms of schizophrenia and affective ...discrete disorder, but with greater ...

8

Combination therapy or monotherapy for the depressed type of schizoaffective disorder

Combination therapy or monotherapy for the depressed type of schizoaffective disorder

... of schizoaffective disorder, however, monotherapy with atypical antipsychotics may be ...of schizoaffective disorder, depressed ...of schizoaffective disorder, depressed ...

12

Show all 6219 documents...

Related subjects